Literature DB >> 13966844

Anginal syndrome. Treatment with a long-acting nitrate (itramin tosylate).

R C BATTERMAN, G J MOURATOFF.   

Abstract

Preliminary studies in eighteen patients with 2-aminoethylnitrate-p-toluene-sulphonate (itramin tosylate) indicate that this organic nitrate is effective and well tolerated for the treatment of the anginal syndrome. Although the dosage should be determined on an individual basis, the administration of a chewing tablet, containing 4 mg. of the medication, appears to be satisfactory.

Entities:  

Keywords:  ANGINA PECTORIS; NITRITES

Mesh:

Substances:

Year:  1963        PMID: 13966844      PMCID: PMC1575756     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  5 in total

1.  Clinical appraisal of analgesic agents.

Authors:  R C BATTERMAN
Journal:  Curr Ther Res Clin Exp       Date:  1962-03

2.  [Electrocardiographic studies on the effect of a new long-acting nitrite preparation (Nilatil)].

Authors:  B EJRUP; T KUMLIN
Journal:  Duodecim       Date:  1961

3.  Clinical aspects for the appraisal of drugs used for the treatment of the anginal syndrome.

Authors:  R C BATTERMAN
Journal:  Ann N Y Acad Sci       Date:  1956-11-16       Impact factor: 5.691

4.  Treatment of congestive heart failure and anginal syndrome with choline theophyllinate.

Authors:  R C BATTERMAN; A J CROSSMAN; J SCHWIMMER; A L BLACKMAN
Journal:  J Am Med Assoc       Date:  1955-01-15

5.  Clinical aspects of the evaluation of analgesic agents.

Authors:  R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1954-07-10
  5 in total
  3 in total

1.  2-Aminoethylnitrate: Earlier investigation as a drug was missed by recent authors due to changes in nomenclature.

Authors:  John Christie McGrath
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  Response to a letter to the editor by Satvika Uppu.

Authors:  Andreas Daiber
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

3.  2-Aminoethylnitrate: pharmacological uses rediscovered and claimed as original.

Authors:  Satvika Uppu
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.